Scarica l'app Stockscreener
118.94
2.92%
3.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Illumina Inc Borsa (ILMN) Ultime notizie
Illumina Inc. Stock (ISIN: US4523271090) Gains on Institutional Buying and Genomic Alliance Momentum - AD HOC NEWS
Illumina (ILMN) Valuation Check As Genomic Discovery Alliance Expansion Draws Fresh Investor Interest - simplywall.st
Is It Time To Reconsider Illumina (ILMN) After Prolonged Share Price Weakness? - Yahoo Finance
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Swiss National Bank Reduces Illumina Holdings - National Today
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Schroder Investment Management Group Sells Illumina Shares - National Today
Schroder Investment Management Group Sells 66,235 Shares of Illumina, Inc. $ILMN - MarketBeat
First Trust Advisors LP Sells 89,600 Shares of Illumina, Inc. $ILMN - MarketBeat
Returns Recap: Does Illumina Inc have consistent dividend growth2026 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
Illumina's new connected multiomics platform set to boost its stock - MSN
Illumina partnership aims to speed rare disease diagnosis in Florida - AADC News
Illumina Stock Climbs 44.8% in a Year: What's Driving the Rally? - The Globe and Mail
Bioinformatics Market to Reach US$ 29.1 Billion by 2031 Growing - openPR.com
Capital International Inc. CA Boosts Stake in Illumina - National Today
Capital International Inc. CA Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
Inceptionr LLC Invests in Illumina, Inc. - National Today
Here’s Why Illumina Stock Could Continue Its 44% Recovery Into 2026 - TIKR.com
Capital World Investors Acquires 3,331,542 Shares of Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Buys 24,055 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Stock Holdings Increased by Capital International Ltd. CA - MarketBeat
Epigenetics Market to Reach US$ 7.10 Billion by 2033 at 14.8% CAGR - openPR.com
Inceptionr LLC Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
How Singapore is solidifying its role at the forefront of global genomics - Illumina
Here's Why Illumina (ILMN) is a Strong Momentum Stock - Yahoo Finance
Neuberger Berman Group Boosts Illumina Stake - National Today
Neuberger Berman Group LLC Purchases 8,135 Shares of Illumina, Inc. $ILMN - MarketBeat
Neo Ivy Capital Management Invests $1.83 Million in Illumina, Inc. $ILMN - MarketBeat
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance
Illumina Stock Hits Day High with Strong 5.54% Intraday Surge - Markets Mojo
Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset - marketscreener.com
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering - Illumina
Illumina (ILMN) Gaining from Stronger Than Expected Results - Insider Monkey
How Illumina Inc. (ILMN) Affects Rotational Strategy Timing - Stock Traders Daily
TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? - TradingView
Integrated Quantitative Investments LLC Acquires New Holdings in Illumina, Inc. $ILMN - MarketBeat
Elo Mutual Pension Insurance Co Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
ARK Investment Management Boosts Stake in Illumina - National Today
ARK Investment Management LLC Has $139.41 Million Position in Illumina, Inc. $ILMN - MarketBeat
Amova Asset Management Americas Inc. Increases Stake in Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term - Nasdaq
DNA Microarray Market is expected to reach US$ 6.12 billion - openPR.com
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
ILMN: Sequencing innovation, clinical growth, and end-to-end solutions drive strong outlook - TradingView
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - TradingView
10,000 Shares in Illumina, Inc. $ILMN Bought by Strive Asset Management LLC - MarketBeat
ILMN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Handelsbanken Fonder AB Boosts Stake in Illumina, Inc. $ILMN - MarketBeat
Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina Inc (ILMN) Trading Down 2.84% on Mar 2 - GuruFocus
Illumina, Inc. (ILMN) Stock Analysis: Exploring The Upside With A 33% Return On Equity - DirectorsTalk Interviews
Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing - Yahoo Finance
Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks
Andra AP fonden Buys 58,209 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Position Boosted by Citigroup Inc. - MarketBeat
Illumina jumps 5.5% as momentum builds after upbeat outlook and multiomics push - Quiver Quantitative
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected MultiomicsPR Newswire APAC - PR Newswire Asia
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - Illumina
Primecap Management Co. CA Sells 73,220 Shares of Illumina, Inc. $ILMN - MarketBeat
Evercore ISI reiterates Illumina stock rating on competitive positioning By Investing.com - Investing.com Australia
Illumina Launches TruPath Genome Unveils NovaSeq X Roadmap and Drives Cancer Breakthroughs with Connected Multiomics - theweek.in
0.34%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):